The hallmarks of mitochondrial dysfunction in chronic kidney disease

Wirthensohn, 1986, Renal substrate metabolism, Physiol Rev, 66, 469, 10.1152/physrev.1986.66.2.469 Zschiedrich, 2017, Targeting mTOR signaling can prevent the progression of FSGS, J Am Soc Nephrol, 10.1681/ASN.2016050519 Brownlee, 2005, The pathobiology of diabetic complications: a unifying mechanism, Diabetes, 54, 1615, 10.2337/diabetes.54.6.1615 Mishra, 2014, Mitochondrial dynamics and inheritance during cell division, development and disease, Nat Rev Mol Cell Biol, 15, 634, 10.1038/nrm3877 Tubbs, 2017, Metabolic signaling functions of ER-mitochondria contact sites: role in metabolic diseases, J Mol Endocrinol, 58, R87, 10.1530/JME-16-0189 Morigi, 2015, Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury, J Clin Invest, 125, 715, 10.1172/JCI77632 Brooks, 2009, Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models, J Clin Invest, 119, 1275, 10.1172/JCI37829 Galloway, 2012, Transgenic control of mitochondrial fission induces mitochondrial uncoupling and relieves diabetic oxidative stress, Diabetes, 61, 2093, 10.2337/db11-1640 Zhan, 2015, Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease, J Am Soc Nephrol, 26, 1304, 10.1681/ASN.2014050457 Ayanga, 2016, Dynamin-related protein 1 deficiency improves mitochondrial fitness and protects against progression of diabetic nephropathy, J Am Soc Nephrol, 27, 2733, 10.1681/ASN.2015101096 Wang, 2012, Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells, Cell Metab, 15, 186, 10.1016/j.cmet.2012.01.009 Han, 2008, CaM kinase I alpha-induced phosphorylation of Drp1 regulates mitochondrial morphology, J Cell Biol, 182, 573, 10.1083/jcb.200802164 Chang, 2007, Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology, J Biol Chem, 282, 21583, 10.1074/jbc.C700083200 Cribbs, 2007, Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death, EMBO Rep, 8, 939, 10.1038/sj.embor.7401062 Puigserver, 1998, A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell, 92, 829, 10.1016/S0092-8674(00)81410-5 Scarpulla, 2008, Transcriptional paradigms in mammalian mitochondrial biogenesis and function, Physiol Rev, 88, 611, 10.1152/physrev.00025.2007 Baldelli, 2013, Punctum on two different transcription factors regulated by PGC-1alpha: nuclear factor erythroid-derived 2-like 2 and nuclear respiratory factor 2, Biochim Biophys Acta, 1830, 4137, 10.1016/j.bbagen.2013.04.006 Dugan, 2013, AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function, J Clin Invest, 123, 4888, 10.1172/JCI66218 Nakatani, 2016, Epigenetic regulation through SIRT1 in podocytes, Curr Hypertens Rev, 12, 89, 10.2174/1573402112666160302102515 Hasegawa, 2013, Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes, Nat Med, 19, 1496, 10.1038/nm.3363 Platt, 2017, Peroxisome proliferator activating receptor-gamma and the podocyte, Nephrol Dial Transplant, 32, 423 Tran, 2016, PGC1alpha drives NAD biosynthesis linking oxidative metabolism to renal protection, Nature, 531, 528, 10.1038/nature17184 Kang, 2015, Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development, Nat Med, 21, 37, 10.1038/nm.3762 Hershberger, 2017, Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases, Nat Rev Nephrol, 13, 213, 10.1038/nrneph.2017.5 Yuan, 2012, Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury, Kidney Int, 82, 771, 10.1038/ki.2012.188 Perico, 2016, Mitochondrial Sirtuin 3 and renal diseases, Nephron, 134, 14, 10.1159/000444370 Sharabi, 2017, Selective chemical inhibition of PGC-1alpha gluconeogenic activity ameliorates type 2 diabetes, Cell, 169, 148, 10.1016/j.cell.2017.03.001 Hartleben, 2010, Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice, J Clin Invest, 120, 1084, 10.1172/JCI39492 Badal, 2015, MicroRNAs and their applications in kidney diseases, Pediatr Nephrol, 30, 727, 10.1007/s00467-014-2867-7 Long, 2010, Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions, J Biol Chem, 285, 23457, 10.1074/jbc.M110.136168 Badal, 2016, miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy, Nat Commun, 7, 12076, 10.1038/ncomms12076 McClelland, 2015, miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7, Clin Sci (Lond), 129, 1237, 10.1042/CS20150427 Zhong, 2013, miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes, Diabetologia, 56, 663, 10.1007/s00125-012-2804-x Long, 2016, Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy, J Clin Invest, 126, 4205, 10.1172/JCI87927 Vendramin, 2017, Non-coding RNAs: the dark side of nuclear-mitochondrial communication, EMBO J, 36, 1123, 10.15252/embj.201695546 Li, 2014, Therapeutic targeting of microRNAs: current status and future challenges, Nat Rev Drug Discov, 13, 622, 10.1038/nrd4359 Dieter, 2015, Novel therapies for diabetic kidney disease: Storied past and forward paths, Diabetes Spectr, 28, 167, 10.2337/diaspect.28.3.167 Galvan DL, Badal SS, Long J, et al. Real-time in vivo mitochondrial redox assessment confirms enhanced mitochondrial reactive oxygen species in diabetic nephropathy [e-pub ahead of print]. Kidney Int. http://dx.doi.org/10.1016/j.kint.2017.05.015. Accessed July 26, 2017. Chen, 2015, EGF receptor deletion in podocytes attenuates diabetic nephropathy, J Am Soc Nephrol, 26, 1115, 10.1681/ASN.2014020192 Sims, 2014, Targeting mitochondrial oxidants may facilitate recovery of renal function during infant sepsis, Clin Pharmacol Ther, 96, 662, 10.1038/clpt.2014.170 Nishi, 2013, Selective estrogen receptor modulation attenuates proteinuria-induced renal tubular damage by modulating mitochondrial oxidative status, Kidney Int, 83, 662, 10.1038/ki.2012.475